 |
8 Diseases |  |
0 Trials |
|
0 Trials |  |
6 News |  |
- ||| ALD-301 / Nuo Therapeutics
Enrollment closed: Patients With Intermittent Claudication Injected With ALDH Bright Cells (clinicaltrials.gov) - Jan 15, 2016
P2, N=82, Active, not recruiting, Sponsor: The University of Texas Health Science Center, Houston
Recruiting --> Active, not recruiting
- || ALD-301 / Nuo Therapeutics
Trial primary completion date: Patients With Intermittent Claudication Injected With ALDH Bright Cells (clinicaltrials.gov) - Nov 10, 2015
P2, N=80, Recruiting, Sponsor: The University of Texas Health Science Center, Houston
Recruiting --> Active, not recruiting Trial primary completion date: Jan 2016 --> Aug 2016
- || ALD-301 / Nuo Therapeutics
Trial primary completion date: Patients With Intermittent Claudication Injected With ALDH Bright Cells (clinicaltrials.gov) - Nov 4, 2014
P2, N=80, Recruiting, Sponsor: The University of Texas Health Science Center, Houston
Trial primary completion date: Jan 2016 --> Aug 2016 Trial primary completion date: Nov 2014 --> Jan 2016
- ALD-301 / Nuo Therapeutics
Enrollment open: Patients With Intermittent Claudication Injected With ALDH Bright Cells (clinicaltrials.gov) - Aug 12, 2013
P2, N=80, Recruiting, Sponsor: The University of Texas Health Science Center, Houston
Trial primary completion date: Nov 2014 --> Jan 2016 Active, not recruiting --> Recruiting
- ALD-301 / Nuo Therapeutics
Trial initiation date: Patients With Intermittent Claudication Injected With ALDH Bright Cells (clinicaltrials.gov) - Jun 18, 2013
P2, N=80, Recruiting, Sponsor: The University of Texas Health Science Center, Houston
Active, not recruiting --> Recruiting Initiation date: Mar 2013 --> Jun 2013
- | ALD-301 / Nuo Therapeutics
New P2 trial: Patients With Intermittent Claudication Injected With ALDH Bright Cells (clinicaltrials.gov) - Jan 21, 2013
P2, N=80, Recruiting, Sponsor: The University of Texas Health Science Center, Houston